February 1, 2019 Kenneth J. HillanVG Acquisition Corp. • May 5th, 2021 • Measuring & controlling devices, nec • California
COLLABORATION AGREEMENT BETWEEN GlaxoSmithKline Intellectual Property (No.3) Limited AND 23andMe, Inc.Collaboration Agreement • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec • Delaware
This Collaboration Agreement (“Agreement”) is made and entered into as of July 24, 2018 (“Execution Date”) and is effective as of the Effective Date (as defined below), by and between GlaxoSmithKline Intellectual Property (No.3) Limited, a company registered in England and Wales (registered number 11480952) with a registered office at 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (“GSK”), and 23andMe, Inc., a company formed under the laws of Delaware whose principal place of business is at 899 West Evelyn Ave., Mountain View, CA 94041 (“23andMe”). GSK and 23andMe are sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.”
FIRST AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec • Delaware
THIS FIRST AMENDMENT (this “Amendment”), dated 8TH April 2019 (the “First Amendment Effective Date”), by and between GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED, a company registered in England and Wales (registered number 11480952) with a registered office at 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (“GSK”) and 23ANDME, INC., a company formed under the laws of Delaware whose principal place of business is at 899 West Evelyn Ave., Mountain View, CA 94041 (“23andMe”) hereby amends the Collaboration Agreement by and between GSK and 23andMe, dated July 24, 2018 (the “Agreement”).
SECOND AMENDMENT TO COLLABORATION AGREEMENTCertain • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec • Delaware
THIS SECOND AMENDMENT (this “Amendment”), dated January 13, 2021 (the “Amendment Effective Date”), by and between GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED, a company registered in England and Wales (registered number 11480952) with a registered office at 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (“GSK”) and 23ANDME, INC., a company formed under the laws of Delaware whose principal place of business is at 223 N Mathilda Ave., Sunnyvale, CA 94086 (“23andMe”), hereby amends the Collaboration Agreement by and between GSK and 23andMe, dated July 24, 2018 (as amended by the First Amendment dated April 8, 2019) (the “Agreement”).
23ANDME, INC. STOCK OPTION AGREEMENTStock Option Agreement • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec • California
This Stock Option Agreement (this “Agreement”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between 23andMe, Inc., a Delaware corporation (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Company’s 2006 Equity Incentive Plan, as amended (the “Plan”).
23andMe, Inc. EMPLOYEE INVENTION ASSIGNMENT AND CONFIDENTIALITY AGREEMENTEmployee Invention Assignment And • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec • California
The following confirms an agreement (“Agreement”) between me and 23andMe, Inc., a Delaware corporation (the “Company”), which is a material part of the consideration for my employment by the Company:
Amendment No. 1 to Consulting AgreementTo Consulting Agreement • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec
This Amendment No. 1 (“Amendment No.1”) is to the Consulting Agreement by and between 23andMe, Inc. (“23andMe”) and Richard Scheller, Ph.D. (“Consultant”) with an Effective Date of April 1, 2019 (“Agreement”). Collectively, 23andMe and Consultant may be referred to as “Parties.” Capitalized terms not defined herein will have the meanings ascribed to them in the Agreement.
CONSULTING AGREEMENTConsulting Agreement • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec • California
This Consulting Agreement sets forth the terms of the consultancy arrangement between the Consultant (as defined below) and 23andMe, Inc. (“23andMe”), as follows:
Amendment No. 2 to Consulting AgreementTo Consulting Agreement • May 5th, 2021 • VG Acquisition Corp. • Measuring & controlling devices, nec
This Amendment No. 2 (“Amendment No. 2”) is to the Consulting Agreement by and between 23andMe, Inc. (“23andMe”) and Richard Scheller, Ph.D. (“Consultant”) with an Effective Date of April 1, 2019 (“Agreement”). Collectively, 23andMe and Consultant may be referred to as “Parties.” Capitalized terms not defined herein will have the meanings ascribed to them in the Agreement.
